EIFVX
Price
$25.15
Change
+$0.21 (+0.84%)
Updated
Jul 31 closing price
Net Assets
72.61M
VIVIX
Price
$85.78
Change
-$0.24 (-0.28%)
Updated
Jul 31 closing price
Net Assets
254.46B
Interact to see
Advertisement

EIFVX vs VIVIX

EIFVX vs VIVIX Comparison Chart in %
View a ticker or compare two or three
VS
EIFVX vs. VIVIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EIFVX is a Buy and VIVIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 254B vs. EIFVX (72.6M). VIVIX pays higher dividends than EIFVX: VIVIX (1.86) vs EIFVX (1.03). EIFVX was incepted earlier than VIVIX: EIFVX (15 years) vs VIVIX (28 years). EIFVX (0.82) is less costly to investors than VIVIX (0.03). EIFVX is a more actively managed with annual turnover of: 118.00 vs. VIVIX (8.00). EIFVX has a lower initial minimum investment than VIVIX: EIFVX (1000000) vs VIVIX (5000000). EIFVX annual gain was more profitable for investors over the last year : 25.93 vs. VIVIX (24.28). VIVIX return over 5 years is better than : 58.89 vs. EIFVX (31.49).
EIFVXVIVIXEIFVX / VIVIX
Total Expense Ratio0.740.032,467%
Annual Report Gross Expense Ratio0.820.032,733%
Fund Existence15 years28 years-
Gain YTD20.73915.125137%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets72.6M254B0%
Annual Yield % from dividends1.031.8655%
Returns for 1 year25.9324.28107%
Returns for 3 years36.0350.2672%
Returns for 5 years31.4958.8953%
Returns for 10 years95.24154.9561%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBACX31.160.26
+0.84%
Touchstone Balanced C
GKIRX28.49-0.01
-0.04%
Goldman Sachs Income Builder Inv
MVCHX34.28-0.10
-0.29%
MFS Mid Cap Value R3
DRLYX9.73-0.08
-0.82%
BNY Mellon Developed Markets RE Scs - Y
AHSAX27.73-0.40
-1.42%
Alger Health Sciences A